Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitor use may reduce the risk for Alzheimer’s disease, Parkinson’s disease and vascular dementia. The ...
Dr. Sam Gandy answers the question: 'Other Causes Of Dementia?' May 4, 2009 -- Question: Could dementia be caused by something other than Alzheimer's disease? Answer: Alzheimer's disease is the most ...
A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...
The study looked at sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are also known as gliflozins. They lower blood sugar by causing the kidneys to remove sugar from the body through urine.
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, ...
The rate of neurodegenerative conditions is growing globally, meaning that a lot of research is into prevention of these problems. There has been some research suggesting that a type of type 2 ...
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson’s disease. The corresponding study was published in Neurology. “We know that these ...
In a recent study posted to the Research Square* preprint server, researchers conducted a meta-analysis after a systematic review of existing literature to understand the association between Androgen ...
Men treated with androgen deprivation therapy (ADT) for prostate cancer had a significantly higher risk of dementia and other neurocognitive disorders, according to a meta-analysis of more than 2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback